C4XD forms discovery partnership with AI company GTN

London, 29th November 2018

C4X Discovery has entered into a drug discovery partnership with artificial intelligence (AI) company GTN.

The partnership aims to maximise insights from shape-based chemistry, and generate novel drug candidates in neurodegeneration.

(Read more about it here)